BSECompany Update2d ago · 29 Jul 2026, 06:32 pm

Intimation for grant of Employee Stock Options

Jagsonpal Pharmaceuticals Ltd · 507789

✦ AI SummaryMgmt Change

Jagsonpal Pharmaceuticals Ltd has informed that the Nomination and Remuneration Committee has approved the grant of 1,20,000 employee stock options under Jagsonpal Pharmaceuticals Limited Employees Stock Option Plan, 2022 at an exercise price of Rs. 179.25 per option.

Analysis Scores

Earnings Impact1/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

Attachments (1)

📄

98b27db7-5d3d-49dc-86fa-ffb78993d6c0.pdf

pdf

Download →
View document text
July 29, 2026 The Department of Corporate Services- Listing The Department of Corporate Services- Listing BSE Ltd, National Stock Exchange of India Ltd Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Dalal Street Bandra Kurla Complex, Mumbai-400 001 Bandra (E) Mumbai – 400 051 Scrip Code: 507789 Symbol: JAGSNPHARM Subject: Intimation for grant of Employee Stock Options Dear Sir/ Madam, We wish to inform you that the Nomination and Remuneration Committee of the Board of Directors at their meeting held on July 29, 2026 has approved the grant of 1,20,000 employee stock options under Jagsonpal Pharmaceuticals Limited Employees Stock Option Plan, 2022 at an exercise price of Rs. 179.25/- per option. The said options, which are convertible into equivalent number of equity shares of Rs. 2.00/- each, will vest in 4 equal annual tranches commencing from the first anniversary of the grant. We request you to take the above on record. Thanking you, For Jagsonpal Pharmaceuticals Limited Pratham Rawal Company Secretary & Compliance officer